Abstract: Endothelial glycocalyx (EG) degradation occurs in septic humans and EG products can be used as biomarkers of endothelial injury. Information about EG biomarkers and their association with disease severity is lacking in hospitalized foals. Objective: Measure serum syndecan-1 (SDC-1), heparan sulfate (HS), angiopoietin-2 (ANG-2), aldosterone (ALD), and plasma atrial natriuretic peptide (ANP) concentrations and to determine their association with disease severity and death in hospitalized foals. Methods: Ninety foals ≤3 days old. Methods: Prospective, multicenter, longitudinal study. Foals were categorized into hospitalized (n = 74; 55 septic; 19 sick nonseptic) and 16 healthy foals. Serum ([SDC-1], [HS], [ANG-2], [ALD]) and plasma (ANP) were measured over 72 hours using immunoassays. Results: Serum ([SDC-1], [HS], [ANG-2], [ALD]) and plasma (ANP) were significantly higher in hospitalized and septic than healthy foals (P < .05). Serum (ANG-2) and plasma (ANP) were significantly higher in hospitalized nonsurvivors than in survivors (P < .05). On admission, hospitalized foals with serum (HS) > 58.7 ng/mL had higher odds of nonsurvival (odds ratio [OR] = 6.1; 95% confidence interval [CI] = 1.02-36.7). Plasma (ANP) >11.5 pg/mL was associated with the likelihood of nonsurvival in hospitalized foals (OR = 7.2; 95% CI = 1.4-37.4; P < .05). Septic foals with serum (ANG-2) >1018 pg/mL on admission had higher odds of nonsurvival (OR = 6.5; 95% CI =1.2-36.6; P < .05). Conclusions: Critical illness in newborn foals is associated with EG degradation and injury, and these biomarkers are related to the severity of disease on admission and the outcome of sick foals.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study investigates the degradation of the endothelial glycocalyx (EG) in critically ill newborn foals and examines several blood biomarkers related to EG injury, assessing their associations with disease severity and survival outcomes.
Background
The endothelial glycocalyx (EG) is a protective layer lining blood vessels, playing a key role in vascular health.
In human sepsis, EG degradation occurs and fragments released during this damage can serve as biomarkers indicating endothelial injury.
There is limited knowledge about EG degradation biomarkers in foals, particularly how these biomarkers relate to disease severity and survival in hospitalized foals.
Objectives of the Study
To measure concentrations of specific biomarkers in the blood of newborn foals, namely:
Syndecan-1 (SDC-1)
Heparan sulfate (HS)
Angiopoietin-2 (ANG-2)
Aldosterone (ALD)
Atrial natriuretic peptide (ANP)
To determine associations between these biomarkers and:
The severity of illness in foals
The likelihood of survival or death
Study Design and Methods
Ninety foals aged 3 days or younger participated in a prospective, multicenter, longitudinal study.
Foals were grouped into:
Hospitalized foals (n=74), which included:
Septic foals (n=55)
Sick, nonseptic foals (n=19)
Healthy foals (n=16)
Blood samples were collected and analyzed over 72 hours using immunoassays to measure:
Serum levels of SDC-1, HS, ANG-2, ALD
Plasma levels of ANP
Key Results
Biomarker Levels:
Hospitalized and septic foals had significantly higher serum levels of SDC-1, HS, ANG-2, ALD, and plasma ANP compared to healthy foals (P < .05).
Association with Survival:
Hospitalized foals that did not survive had significantly higher serum ANG-2 and plasma ANP compared to survivors (P < .05).
On admission, foals with serum HS levels above 58.7 ng/mL had 6.1 times higher odds of not surviving (95% CI: 1.02-36.7).
Foals with plasma ANP levels above 11.5 pg/mL had 7.2 times higher odds of nonsurvival (95% CI: 1.4-37.4; P<.05).
Among septic foals, those with serum ANG-2 levels over 1018 pg/mL had 6.5 times higher odds of dying (95% CI: 1.2-36.6; P<.05).
Conclusions and Implications
Endothelial glycocalyx degradation occurs in critically ill newborn foals, particularly those hospitalized with sepsis.
The elevated concentrations of EG biomarkers are correlated with increased disease severity and a higher risk of death.
These biomarkers (SDC-1, HS, ANG-2, ALD, ANP) can be used to evaluate endothelial injury in foals and may serve as important tools for prognosis.
Monitoring these biomarkers on admission could help veterinarians identify foals at greater risk and guide therapeutic decision-making.
Significance of the Study
This study adds valuable knowledge about EG degradation in veterinary medicine, specifically in neonatal foals.
It provides baseline data for biomarker levels related to EG injury in healthy versus critically ill foals.
It highlights the potential for these biomarkers to predict outcomes, which can improve clinical management of foal sepsis and other critical illnesses.
Cite This Article
APA
Gomez DE, Kamr A, Gilsenan WF, Burns TA, Mudge MC, Hostnik LD, Toribio RE.
(2024).
Endothelial glycocalyx degradation in critically ill foals.
J Vet Intern Med, 38(5), 2748-2757.
https://doi.org/10.1111/jvim.17196
Chappell D, Bruegger D, Potzel J. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx.. Crit Care 2014;18(5):538.
Bruegger D, Jacob M, Rehm M. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of Guinea pig hearts.. Am J Physiol Heart Circ Physiol 2005;289(5):H1993‐H1999.
Lupu F, Kinasewitz G, Dormer K. The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis.. J Cell Mol Med 2020;24(21):12258‐12271.
Chalkias A. Shear stress and endothelial mechanotransduction in trauma patients with hemorrhagic shock: hidden coagulopathy pathways and novel therapeutic strategies.. Int J Mol Sci 2023;24(24):17522.
Vittum Z, Cocchiaro S, Mensah SA. Basal endothelial glycocalyx's response to shear stress: a review of structure, function, and clinical implications.. Front Cell Dev Biol 2024;12:1371769.
Schött U, Solomon C, Fries D, Bentzer P. The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review.. Scand J Trauma Resusc Emerg Med 2016;24:48.
Hirota T, Levy JH, Iba T. The influence of hyperglycemia on neutrophil extracellular trap formation and endothelial glycocalyx damage in a mouse model of type 2 diabetes.. Microcirculation 2020;27(5):e12617.
Selim J, Hamzaoui M, Boukhalfa I. Cardiopulmonary bypass increases endothelial dysfunction after pulmonary ischaemia‐reperfusion in an animal model.. Eur J Cardiothorac Surg 2021;59(5):1037‐1047.
Martin JV, Liberati DM, Diebel LN. Excess sodium is deleterious on endothelial and glycocalyx barrier function: a microfluidic study.. J Trauma Acute Care Surg 2018;85(1):128‐134.
Rezazadeh F. Measurement of biomarkers troponin I, NT pro BNP and ANP between horses with signs of respiratory disease and apparently healthy group.. Anim Vet Sci 2016;4(6):86.
Yagmur E, Koch A, Haumann M, Kramann R, Trautwein C, Tacke F. Hyaluronan serum concentrations are elevated in critically ill patients and associated with disease severity.. Clin Biochem 2012;45(1–2):82‐87.
Smart L, Macdonald SPJ, Burrows S, Bosio E, Arendts G, Fatovich DM. Endothelial glycocalyx biomarkers increase in patients with infection during Emergency Department treatment.. J Crit Care 2017;42:304‐309.
Jiménez M, Cervantes‐García D, Córdova‐Dávalos LE, Pérez‐Rodríguez MJ, Gonzalez‐Espinosa C, Salinas E. Responses of mast cells to pathogens: beneficial and detrimental roles.. Front Immunol 2021;12:685865.
Okada H, Takemura G, Suzuki K. Three‐dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions.. Crit Care 2017;21(1):261.
Sieve I, Münster‐Kühnel AK, Hilfiker‐Kleiner D. Regulation and function of endothelial glycocalyx layer in vascular diseases.. Vascul Pharmacol 2018;100:26‐33.
Abou‐Arab O, Kamel S, Beyls C. Vasoplegia after cardiac surgery is associated with endothelial glycocalyx alterations.. J Cardiothorac Vasc Anesth 2020;34(4):900‐905.
Suri C, Jones PF, Patan S. Requisite role of angiopoietin‐1, a ligand for the TIE2 receptor, during embryonic angiogenesis.. Cell 1996;87(7):1171‐1180.
Salmon AHJ, Neal CR, Sage LM, Glass CA, Harper SJ, Bates DO. Angiopoietin‐1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx.. Cardiovasc Res 2009;83(1):24‐33.
Parikh SM, Mammoto T, Schultz A. Excess circulating angiopoietin‐2 may contribute to pulmonary vascular leak in sepsis in humans.. PLoS Med 2006;3(3):e46.
Wright JK, Hayford K, Tran V. Biomarkers of endothelial dysfunction predict sepsis mortality in young infants: a matched case‐control study.. BMC Pediatr 2018;18(1):118.
Liu XW, Ma T, Liu W. Sustained increase in angiopoietin‐2, heparin‐binding protein, and procalcitonin is associated with severe sepsis.. J Crit Care 2018;45:14‐19.
Yu WK, McNeil JB, Wickersham NE, Shaver CM, Bastarache JA, Ware LB. Angiopoietin‐2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure.. Crit Care 2021;25(1):48.
Jacob M, Saller T, Chappell D, Rehm M, Welsch U, Becker BF. Physiological levels of A‐, B‐ and C‐type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability.. Basic Res Cardiol 2013;108(3):347.
Witthaut R, Busch C, Fraunberger P. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin‐6 and sepsis‐associated left ventricular dysfunction.. Intensive Care Med 2003;29(10):1696‐1702.
Crompton M, Skinner LJ, Satchell SC, Butler MJ. Aldosterone: essential for life but damaging to the vascular endothelium.. Biomolecules 2023;13(6):1004.
Saoraya J, Wongsamita L, Srisawat N, Musikatavorn K. Plasma syndecan‐1 is associated with fluid requirements and clinical outcomes in emergency department patients with sepsis.. Am J Emerg Med 2021;42:83‐89.
Anand D, Ray S, Srivastava LM, Bhargava S. Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients.. Clin Biochem 2016;49(10–11):768‐776.
Huang X, Hu H, Sun T. Plasma endothelial glycocalyx components as a potential biomarker for predicting the development of disseminated intravascular coagulation in patients with sepsis.. J Intensive Care Med 2021;36(11):1286‐1295.
Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma.. Shock 2008;30(6):623‐627.
Johansson PI, Bergström A, Aachmann‐Andersen NJ. Effect of acute hypobaric hypoxia on the endothelial glycocalyx and digital reactive hyperemia in humans.. Front Physiol 2014;5:459.
Bruegger D, Brettner F, Rossberg I. Acute degradation of the endothelial glycocalyx in infants undergoing cardiac surgical procedures.. Ann Thorac Surg 2015;99(3):926‐931.